Macy's Inc vs GeneDx Holdings Corp — how do they compare? Macy's Inc trades at $23.78 (market cap $6.13B), while GeneDx Holdings Corp trades at $61.92 (market cap $1.80B). The key difference: Macy's Inc is far larger — about 3.4× GeneDx Holdings Corp's market cap, and Macy's Inc pays a 3.29% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| M | WGS | |
|---|---|---|
Market Cap | $6.13B | $1.80B |
Sector | Consumer Cyclical | Technology |
52-Week High | $25.96 | $167.51 |
52-Week Low | $11.90 | $34.51 |
Enterprise Value | $9.95B | $1.80B |
Dividend Yield | 3.29% | — |
Signals from Pluang's Aura AI — not financial advice
Macy's (M) trades at $23.80, up 0.51% today, with a bullish technical signal and strong recent earnings beats. The stock shows improving fundamentals with a 2.94% net margin and attractive valuation at a P/E of 9.63. Recent news highlights a successful turnaround under the 'Bold New Chapter' strategy, including same-store sales growth and digital innovation initiatives.
Outlook remains positive with analyst consensus target at $24.83, though risks include margin pressure and retail competition. The stock offers value with upside potential from operational improvements, supported by Berkshire Hathaway's recent 3 million share purchase disclosed in Q1 2026 (13F filing May 15, 2026).
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Founded in 1858 and based in New York City, Macy's operates 570 stores under the Macy's nameplate, 58 stores under the Bloomingdale's nameplate, and 160 freestanding Bluemercury specialty beauty stores (as of the end of fiscal-year 2021). Macy's also operates e-commerce sites and licenses two Bloomingdale's stores in the United Arab Emirates and Kuwait. Women's apparel, accessories, shoes, cosmetics, and fragrances comprised 59% of Macy's 2021 sales.
Read more on M →GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →